# Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)

Study · id `cardio:ct-nct02193971` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02193971](<https://clinicaltrials.gov/study/NCT02193971>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02193971

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3429 participants.

## Technical summary

Registry record NCT02193971. Randomized; no masking; primary purpose treatment. Start 2014-07 (actual); primary completion 2020-10 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 3429 participants (enrolled count; ClinicalTrials.gov record NCT02193971, source copy `cardio:ctgov-nct02193971-2026-04-27`, retrieved 2026-10-31)
- Started: 2014-07 (actual) (ClinicalTrials.gov record NCT02193971, source copy `cardio:ctgov-nct02193971-2026-04-27`, retrieved 2026-10-31)
- Primary completion: 2020-10 (actual) (ClinicalTrials.gov record NCT02193971, source copy `cardio:ctgov-nct02193971-2026-04-27`, retrieved 2026-10-31)
- Completion: 2024-01 (actual) (ClinicalTrials.gov record NCT02193971, source copy `cardio:ctgov-nct02193971-2026-04-27`, retrieved 2026-10-31)
- Countries: South Korea (ClinicalTrials.gov record NCT02193971, source copy `cardio:ctgov-nct02193971-2026-04-27`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02193971-2026-04-27`, retrieved 2026-10-31)

## The registry's words

- Brief title: Harmonizing Optimal Strategy for Treatment of Coronary Artery Diseases Trial - Comparison of REDUCTION of PrasugrEl Dose & POLYmer TECHnology in ACS Patients (HOST REDUCE POLYTECH RCT Trial)
- Condition: Acute Coronary Syndrome
- Intervention (Device): BS-DES (Biostable polymer drug-eluting stent)
- Intervention (Device): BD-DES (Biodegradable polymer drug-eluting stent)
- Intervention (Drug): Prasugrel 5mg
- Lead sponsor: Seoul National University Hospital
- Lead sponsor class: OTHER
- Collaborator: Boston Scientific Korea Co. Ltd
- Collaborator class: INDUSTRY
- Collaborator: Dio
- Collaborator class: INDUSTRY
- Collaborator: Terumo Corporation
- Collaborator class: INDUSTRY
- Collaborator: Abbott
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry lists this organization as the lead sponsor: Seoul National University Hospital (`cardio:org-seoul-national-university-hospital`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

### Other papers using this trial's data

- Registry lists this paper as a reference of type result; PubMed dates it on or after the trial start and types it as a trial report, neither its types nor its title mark it as a protocol, a review or a comment, the paper names no other trial in place of this one, and PubMed shows no retraction or expression of concern; it is not marked as the trial's main report: Durable-polymer versus biodegradable-polymer drug-eluting stents in acute coronary syndromes: three-year outcomes of the HOST REDUCE POLYTECH RCT Trial (`cardio:pubmed-38887886`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome: The HOST-REDUCE-POLYTECH-ACS Trial (`cardio:pubmed-33205662`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS Trial (`cardio:pubmed-35262625`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trial (`cardio:pubmed-36715152`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: b6e4c4d39e17822a6df11af46108cf73e3cdeb2905c85ab1f2d42ef8bd106ad6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
